Graves disease - when the thyroid accelerator gets stuck

What Graves disease is, why it makes the whole body run too fast, and how to choose between tablets, radioiodine and surgery

TSH receptor antibodies bypass the normal feedback system and keep the thyroid switched on

The short version  Graves' disease is treatable, but there is no single treatment that is best for everybody. The right choice depends on how active the disease is, the size of the thyroid, whether the eyes are involved, pregnancy plans, other health conditions and - importantly - what trade-offs feel acceptable to you.

The day the thermostat stopped listening

Imagine that your thyroid is a boiler and your pituitary gland is the thermostat. Under normal circumstances, the thermostat sends a signal called thyroid-stimulating hormone, or TSH. When enough thyroid hormone has been made, the thermostat turns the signal down. Quiet room. Sensible temperature. Everyone gets on with the day.

In Graves' disease, the immune system produces antibodies that fit the thyroid's TSH receptor. They behave like counterfeit keys. Even when the pituitary has reduced TSH to almost nothing, the antibodies keep turning the receptor and telling the thyroid to make more hormone. The thyroid is not being disobedient. It is receiving a convincing false instruction.

The result is excess T4 and T3. These hormones influence almost every tissue, so Graves' disease rarely limits itself to one polite symptom. The heart beats faster, muscles burn fuel less efficiently, the body produces more heat, the gut may hurry, sleep becomes lighter and the brain can feel as though somebody has replaced its calm background music with a drum solo.

Why Graves disease happens

Graves' disease is an autoimmune condition. The immune system, whose day job is recognising infections, mistakenly makes TSH receptor antibodies, usually abbreviated to TRAb. Genes create susceptibility, while factors such as smoking, major physiological stress, pregnancy and the months after delivery may influence when the illness appears. In most individuals there is no single event that can be blamed, and it is certainly not something the patient caused through diet, personality or insufficient yoga.

The thyroid often enlarges because the antibody signal promotes both hormone production and thyroid growth. Some people also develop thyroid eye disease. Here, the autoimmune process activates tissues behind and around the eyes. That is why eye disease can occasionally behave differently from the thyroid blood tests and why smoking matters so much: smoking substantially increases the risk and severity of thyroid eye disease.

What excess thyroid hormone does to the body

	What Happens?
Heart and circulation	Palpitations, a fast pulse, breathlessness and sometimes atrial fibrillation occur because thyroid hormone makes the cardiovascular system more responsive to adrenaline.
Heat and energy	Heat intolerance, sweating and weight loss occur because resting energy use rises. Weight does not always fall; increased appetite can keep pace with the faster metabolism.
Muscles and bones	Proximal muscle weakness, reduced stamina and tremor reflect increased protein turnover and adrenergic drive. Prolonged untreated disease can accelerate bone loss.
Brain and sleep	Anxiety, irritability, poor concentration and broken sleep are biological effects of thyrotoxicosis. They are not evidence that the illness is imaginary.
Periods and fertility	Cycles may become lighter or irregular, and fertility can be affected until thyroid function is controlled.
Eyes	Grittiness, watering, light sensitivity, lid swelling, staring appearance or double vision may signal thyroid eye disease. Colour vision loss, reduced vision or severe pain needs urgent assessment.

How the diagnosis is confirmed

The usual biochemical pattern is a suppressed TSH with raised free T4, free T3 or both. T3 can be disproportionately high, so checking it matters. A TRAb blood test usually confirms that Graves' disease is the cause. If the antibody result is negative or the diagnosis remains uncertain, a thyroid uptake scan may help distinguish Graves' disease from thyroiditis or autonomous nodules. A scan is not used during pregnancy.

An ultrasound is useful when there is a palpable nodule, a very large goitre or uncertainty about the anatomy. It is not automatically required for every straightforward case. The clinician should also assess pulse, blood pressure, heart rhythm, thyroid size, eye features, pregnancy plans and medicines that might complicate treatment.

The first job is to calm the system

Before deciding on the long-term route, symptoms often need prompt relief. A beta blocker can reduce palpitations, tremor and the uncomfortable sense that the body is permanently late for a train. It works within hours because it blocks some effects of adrenaline. It does not switch off thyroid hormone production, so it is a bridge rather than a cure. Asthma, low blood pressure, a slow pulse and some heart conditions may alter which drug can be used.

Carbimazole is commonly started at the same time to reduce new thyroid hormone production. Severe thyrotoxicosis, atrial fibrillation, heart failure, pregnancy, significant eye disease or concern about thyroid storm needs more urgent and individualised care.

Three routes with three different bargains

The three established treatments are antithyroid medication, radioactive iodine and thyroidectomy. All can control Graves' hyperthyroidism. They differ in speed, reversibility, practical burden, effect on the eyes and likelihood of leaving the patient dependent on levothyroxine.

It helps to separate three goals. Control means bringing T4 and T3 into a safe range. Remission means Graves' hyperthyroidism stays away after medication is stopped. Definitive treatment means removing or disabling enough thyroid tissue that recurrent hyperthyroidism becomes very unlikely; hypothyroidism is then expected and treated with levothyroxine.

Option 1: antithyroid medication

How carbimazole works

Carbimazole is converted in the body to methimazole. It blocks thyroid peroxidase, an enzyme the thyroid needs to attach iodine to proteins and manufacture T4 and T3. It prevents new hormone being made but does not instantly empty the hormone already stored in the gland. That explains why blood tests and symptoms improve over weeks rather than by teatime.

Medication controls hormone production while the immune activity may settle. A conventional course lasts about 12 to 18 months. Some patients then remain in remission; others relapse because the antibodies are still active. A small thyroid, milder biochemical disease, low or negative TRAb and no smoking make remission more likely. A large goitre, high TRAb, severe disease and smoking make relapse more likely, but none of these predicts an individual's future with certainty.

What treatment is like in real life

Before treatment, clinicians commonly check a full blood count and liver tests. Thyroid blood tests are repeated fairly frequently at first, often every four to six weeks, and the dose is adjusted to free T4 and free T3. TSH may remain suppressed for months after hormone levels improve; it is a slow witness and should not be allowed to overrule the more immediate evidence early in treatment.

Most UK patients use a titration regimen: the carbimazole dose is reduced as the thyroid settles. A block-and-replace regimen uses a higher carbimazole dose to stop production and then adds levothyroxine. It can simplify some fluctuations but exposes the patient to more antithyroid drug and is unsuitable during pregnancy. The choice is individual.

Benefits of medication

• It is reversible and avoids radiation, an operation and immediate permanent hypothyroidism.

• It is often a good first approach for mild or moderate disease, a smaller goitre and a reasonable chance of remission.

• It is usually preferred while active moderate or severe thyroid eye disease is being managed.

• Long-term low-dose treatment can be reasonable for selected patients who tolerate it well and prefer continuing tablets to definitive treatment.

  
  

Limitations and side effects of medication

Rash, itching, nausea, headache and joint discomfort are the more familiar nuisances. Serious reactions are uncommon but important. Agranulocytosis is a sudden, dangerous fall in infection-fighting white blood cells. It occurs in roughly 1 to 3 people per 1,000 treated patients in large series, most often early in treatment, though it can occur later or after re-exposure.

The sore throat rule  If you develop a fever, significant sore throat, mouth ulcers or flu-like illness while taking carbimazole or propylthiouracil, stop the tablets and seek same-day medical advice for an urgent blood count. Do not take the next dose until a clinician has advised you. A calendar reminder is not an adequate white-cell test.

Seek prompt advice for jaundice, dark urine, pale stools, marked abdominal pain, severe itching or unusual bruising. Carbimazole can rarely cause liver injury or pancreatitis. Propylthiouracil has a greater concern for serious liver injury, which is one reason carbimazole is preferred outside early pregnancy and a few special situations.

The other limitation is relapse. A standard course offers a genuine chance of remission, but it is not a promise. If Graves' disease returns, the choices include another course, long-term low-dose medication, radioiodine or surgery. Relapse is information, not a moral verdict on either the patient or the tablet.

Option 2: radioactive iodine

How radioiodine works

The thyroid is unusually enthusiastic about collecting iodine because iodine is the raw material for thyroid hormone. Radioactive iodine uses that enthusiasm against the gland. A capsule or drink containing iodine-131 is swallowed; thyroid cells take it up, and the short-range radiation gradually reduces their function.

The goal in Graves' disease is usually to cure the hyperthyroidism, accepting that hypothyroidism is likely and will require lifelong levothyroxine. Most patients need one dose, but a minority need another. Improvement takes weeks and the full effect may take several months, so antithyroid medication and a beta blocker may be needed around the treatment according to the nuclear medicine plan.

What treatment is like in real life

Radioiodine is usually an outpatient treatment. A pregnancy test is required where relevant. The nuclear medicine team gives precise instructions about pausing antithyroid drugs, avoiding excess iodine and limiting close contact after treatment. Restrictions vary with the administered dose and local radiation calculations. They may affect contact with young children or pregnant people, sleeping arrangements, work and travel for a period. This practical detail can matter greatly to a parent, carer or teacher and should be discussed before booking the dose.

Blood tests are needed every four to six weeks initially because thyroid function can move from high to low. Levothyroxine starts when hypothyroidism develops. TSH can lag here too, so free T4 and symptoms remain important during the transition.

Benefits of radioiodine

• It is highly effective, avoids general anaesthesia and usually requires only one outpatient dose.

• It suits many patients who want definitive treatment but do not want surgery.

• It can be useful when antithyroid drugs have caused significant side effects or Graves disease has relapsed.

• There is no surgical scar or risk of recurrent laryngeal nerve injury or postoperative hypocalcaemia.

  
  

Limitations and side effects of radioiodine

It is not an instant off-switch. Symptoms can fluctuate during the first months, and rarely hyperthyroidism temporarily worsens. Permanent hypothyroidism is expected rather than accidental. Some patients prefer that predictable endpoint; others place high value on retaining their own thyroid if possible.

Radioiodine can trigger or worsen thyroid eye disease, particularly in smokers, people with active eye disease, high TRAb or poorly controlled thyroid levels. Steroid cover can reduce risk in selected patients, but active moderate or severe eye disease usually pushes the decision towards medication or surgery. Smoking cessation is one of the most useful eye treatments available, although it is admittedly less glamorous than a new prescription.

Radioiodine must not be used during pregnancy or breastfeeding. Pregnancy should be postponed for at least six months afterwards and until thyroid levels are stable; local advice also applies to men planning fatherhood. TRAb can rise after radioiodine, which matters when pregnancy is planned because these antibodies can cross the placenta.

Option 3: total thyroidectomy

How surgery works

Total thyroidectomy removes the tissue producing excess hormone. It is the fastest and most certain definitive treatment, and recurrence is very uncommon when the whole gland is removed. The trade-off is immediate lifelong dependence on levothyroxine.

What treatment is like in real life

Whenever possible, thyroid levels are controlled with carbimazole before surgery, often with a beta blocker. Some teams prescribe iodine solution for a short period before the operation to reduce thyroid blood flow. Calcium and vitamin D are checked and corrected where necessary. The procedure requires general anaesthesia, usually followed by a short hospital stay. Levothyroxine begins after surgery, and calcium is monitored.

The surgeon's experience matters. Graves' glands are vascular and technically more demanding than an ordinary thyroid nodule. A high-volume thyroid surgeon has lower complication rates and should be sought whenever possible.

Benefits of surgery

• It gives rapid and reliable control without radiation.

• It is often favoured for a large goitre, pressure symptoms, a suspicious nodule or coexisting thyroid cancer concern.

• It is often the preferred definitive treatment when significant active thyroid eye disease makes radioiodine unattractive.

• It can suit someone planning pregnancy soon once thyroid levels have been stabilised, because there is no post-radioiodine waiting period.

• It removes the need for continuing antithyroid medication and its rare serious reactions.

  
  

Limitations and side effects of surgery

Short-term neck discomfort, a scar and temporary voice change are common practical concerns. Important complications include bleeding in the neck, infection, injury to the recurrent or superior laryngeal nerves and low calcium due to disturbance of the parathyroid glands. Low calcium is often temporary; permanent hypoparathyroidism and permanent nerve injury are uncommon in expert hands but can have lifelong consequences. Anaesthetic risk and recovery time also matter.

After total thyroidectomy, levothyroxine is essential for life. Most patients feel entirely well once the dose is established. A minority report persistent symptoms despite a satisfactory TSH, a point that deserves honest discussion before an irreversible treatment rather than being reduced to 'just one tablet each morning.' This does not make surgery a poor treatment. It makes informed consent a proper conversation.

The options at a glance

	Antithyroid Medication	Radioiodine	Total Thyroidectomy
Main aim	Control now with a chance of remission	Definitive treatment by gradually disabling the thyroid	Definitive treatment by removing the thyroid
Speed	Symptoms improve over days to weeks; hormones over weeks	Usually weeks to months	Rapid once surgery is completed
Thyroid retained	Yes	Often little useful function remains	No
Ongoing practical burden	Daily tablets and repeated blood tests; relapse monitoring	Radiation precautions and frequent early blood tests	Operation and recovery, then daily levothyroxine and monitoring
Eye disease	Often preferred during active significant eye disease	May worsen eye disease; avoid or protect selected patients	Often favoured when definitive treatment is needed
Pregnancy	Usable with specialist choice and lowest effective dose	Never during pregnancy or breastfeeding; conception delayed afterwards	Occasionally in second trimester if essential; often useful before pregnancy
Main serious risks	Agranulocytosis and liver injury	Eye disease worsening; delayed hypothyroidism or persistent hyperthyroidism	Bleeding, nerve injury, hypocalcaemia and anaesthetic complications
Likely long term result	Remission, relapse or long-term low-dose treatment	Usually lifelong levothyroxine	Lifelong levothyroxine

Which patient factors move the decision

Mild disease, small goitre, low TRAb and first episode	A course of carbimazole offers a reasonable chance of remission and preserves the thyroid.
Large goitre, pressure symptoms or suspicious nodule	Surgery deals with both the hormone problem and the structural problem.
Active moderate or severe thyroid eye disease	Antithyroid medication is generally preferred while the eyes are active. If definitive treatment is needed, surgery is usually favoured over radioiodine.
Smoking	Raises the risk of eye disease and makes radioiodine less attractive, particularly if eye features or high TRAb are present.
Pregnancy desired within the near future	Preconception control is essential. Surgery before conception may be preferable when definitive treatment is needed; radioiodine requires a waiting period and may raise TRAb.
Relapse after a standard medication course	Another course, long-term low-dose medication, radioiodine and surgery can all be reasonable. The prior response and patient preference matter.
Severe drug reaction	Usually rules out further use of the responsible antithyroid drug and pushes the choice towards radioiodine or surgery.
Major surgical or anaesthetic risk	May favour medication or radioiodine.
Need for rapid definitive control	Usually favours surgery once the patient is safely prepared.
Strong wish to avoid lifelong levothyroxine	Favors a medication-first strategy, while accepting monitoring and the possibility of relapse.
Difficulty following radiation precautions	May make radioiodine impractical even when it is medically suitable.
Access to an expert thyroid surgeon	Changes the risk-benefit balance. Surgery should not be treated as the same operation regardless of who performs it.

Thyroid eye disease changes the rules

Eye symptoms deserve specific assessment rather than being filed under 'the thyroid will settle.' Mild grittiness and watering may respond to lubricating drops, stable thyroid function and smoking cessation. Double vision, marked swelling, inability to close the lids or visual change needs specialist ophthalmic assessment. Reduced colour vision, loss of sight or severe pain is urgent.

The activity and severity of eye disease influence the thyroid treatment. Radioiodine is a recognised risk factor for progression, especially when other risks coexist. If radioiodine remains the chosen option in mild active disease, steroid prophylaxis may be advised. In active moderate or severe disease, antithyroid drugs are generally preferred for controlling hyperthyroidism while specialist eye treatment proceeds.

Graves disease and pregnancy

Before conception

Pregnancy is safest when Graves' disease is stable before conception. Preconception counselling should review current control, medication dose, TRAb, eye disease and the desired timeline. A person considering radioiodine must postpone pregnancy for at least six months afterwards and until thyroid function is stable. Definitive treatment does not immediately remove the antibodies: TRAb can persist after surgery and may rise after radioiodine.

During pregnancy

Radioiodine is never used in pregnancy. Antithyroid medication is the usual treatment when overt Graves' hyperthyroidism requires therapy. Propylthiouracil is generally preferred around conception and in the first trimester because carbimazole is associated with a characteristic, uncommon pattern of birth defects, particularly with higher first-trimester exposure. After the first trimester, many UK teams change back to carbimazole to reduce the risk of serious propylthiouracil-related liver injury. This switch needs specialist supervision; the doses are not equivalent.

The aim is the lowest dose that keeps maternal free T4 in the upper part of the pregnancy-specific range. Trying to make the TSH look beautifully normal can overtreat the fetal thyroid because antithyroid drugs cross the placenta. Block-and-replace treatment is therefore avoided. Blood tests are usually repeated every two to four weeks early in pregnancy and less often once stable.

TRAb also crosses the placenta. For that reason, antibody monitoring may be required even if the mother previously had radioiodine or thyroidectomy and now takes levothyroxine. High antibodies, uncontrolled disease or continuing antithyroid treatment may lead to additional fetal growth, heart-rate and thyroid surveillance. The antibody has not read the operative note; it only knows how to cross a placenta.

Surgery during pregnancy is uncommon. If medication cannot be used or control is impossible and surgery is essential, the second trimester is usually the safest window. Planning should involve endocrinology, obstetrics, fetal medicine and an experienced thyroid surgeon.

After delivery and breastfeeding

Graves' disease often becomes quieter during pregnancy and can flare after delivery as the immune system rebounds. Thyroid function should therefore be checked postpartum. Carbimazole and propylthiouracil can be used during breastfeeding at appropriate doses under specialist supervision. Radioiodine treatment is not compatible with ongoing breastfeeding. The baby's thyroid may need assessment when maternal TRAb is high or antithyroid drugs were required during pregnancy.

What happens after the chosen treatment

Whatever route is chosen, the story continues beyond the first normal blood test. After medication is stopped, relapse can occur months or years later, so recurrent palpitations, tremor, heat intolerance or unexplained weight change should prompt a test. After radioiodine or surgery, levothyroxine needs careful titration and lifelong monitoring. Eye disease can remain active or emerge even when thyroid levels are normal.

Recovery may also lag behind biochemistry. Muscles need rebuilding, sleep needs restoring and the nervous system needs time to stop behaving as though a fire alarm is still ringing. Persistent symptoms deserve a thoughtful review for thyroid status, anaemia, sleep disorders, mood, medication effects and other causes. A normal result is reassuring, but it should begin clinical reasoning rather than end the conversation.

When to seek urgent help

• Chest pain, fainting, severe breathlessness, a very fast or irregular pulse, confusion, high fever or marked agitation.

• Loss of vision, altered colour vision, severe eye pain or inability to close the eyelids.

• Fever, sore throat, mouth ulcers or flu-like illness while taking carbimazole or propylthiouracil. Stop the drug and obtain same-day advice and a blood count.

• Jaundice, dark urine, pale stools or severe abdominal pain while taking an antithyroid drug.

• A positive pregnancy test or suspected pregnancy while taking antithyroid medication. Contact the treating team promptly; do not simply abandon treatment without advice.

  
  

Questions worth taking to the consultation

1.       How severe is my Graves disease, and what do my thyroid size and TRAb suggest about remission or relapse?

2.       Do I have thyroid eye disease, and does that make radioiodine a poor choice?

3.       Am I hoping for symptom control, a chance of remission, or the most rapid definitive treatment?

4.       How would each option affect pregnancy plans, caring responsibilities, work and travel?

5.       If I choose surgery, how many thyroidectomies does the surgeon perform and what are their complication rates?

6.       If I choose radioiodine, what exact contact restrictions will apply in my household?

7.       If I choose medication, what is the monitoring plan and exactly what should I do if I develop a fever or sore throat?

8.       How do we review the decision if my priorities or the disease change?

The decision is allowed to be personal

A younger patient with a small thyroid, mild disease and low TRAb may reasonably choose carbimazole and give remission a chance. A patient with a large compressive goitre and a suspicious nodule may sensibly prefer surgery. Someone with no eye disease, no near-term pregnancy plans and a strong wish to avoid an operation may choose radioiodine. The same diagnosis can produce three different good decisions because the patients are not interchangeable.

A proper Graves' consultation should therefore do more than name three treatments. It should explain what each treatment is trying to achieve, what daily life will look like, what can go wrong and which consequences are reversible. Once those pieces are visible, the decision becomes less like choosing a door in the dark and more like choosing a route on a well-lit map.

Further reading

1. National Institute for Health and Care Excellence. Thyroid disease assessment and management. NICE guideline NG145. Read source

2. Ross DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26:1343-1421. Read source

3. Kahaly GJ, et al. 2018 European Thyroid Association Guideline for the Management of Graves Hyperthyroidism. European Thyroid Journal. 2018;7:167-186. Read source

4. Bartalena L, et al. 2021 EUGOGO clinical practice guidelines for the medical management of Graves orbitopathy. European Journal of Endocrinology. 2021;185:G43-G67. Read source

5. Chan SY, et al. Management of Thyroid Disorders in Pregnancy. RCOG Green-top Guideline No 76. BJOG. 2025;132:e130-e161. Read source

6. NHS. Treatment for an overactive thyroid. Read source

7. NHS. Side effects of carbimazole. Read source

8. Medicines and Healthcare products Regulatory Agency. Carbimazole increased risk of congenital malformations and strengthened advice on contraception. Read source

9. Abraham-Nordling M, et al. Graves disease a long-term quality-of-life follow-up of patients randomised to antithyroid drugs, radioiodine or surgery. Thyroid. 2005;15:1279-1286. Read source